000403 派林生物
已收盘 10-09 15:00:00
资讯
新帖
简况
派林生物（000403）披露回购公司股份进展公告，10月8日股价下跌2.19%
证券之星 · 10-08 22:59
派林生物（000403）披露回购公司股份进展公告，10月8日股价下跌2.19%
派林生物（000403）9月30日主力资金净买入166.41万元
证券之星 · 10-08 09:06
派林生物（000403）9月30日主力资金净买入166.41万元
股市必读：派林生物新发布《北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2026年第三次临时股东会的法律意见书》
证券之星 · 09-11
股市必读：派林生物新发布《北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2026年第三次临时股东会的法律意见书》
派林生物（000403）披露2026年度中期利润分配方案，9月10日股价下跌1.71%
证券之星 · 09-10
派林生物（000403）披露2026年度中期利润分配方案，9月10日股价下跌1.71%
每周股票复盘：派林生物（000403）股东户数下降3.78%
证券之星 · 09-06
每周股票复盘：派林生物（000403）股东户数下降3.78%
派林生物半年报遇冷：业绩加速下滑，多重风险交织
新浪证券 · 09-04
派林生物半年报遇冷：业绩加速下滑，多重风险交织
派林生物(000403)8月31日股东户数3.55万户，较上期减少3.78%
证券之星 · 09-03
派林生物(000403)8月31日股东户数3.55万户，较上期减少3.78%
派林生物：公司截止2026年8月31日股东人数35458户
证券之星 · 09-03
派林生物：公司截止2026年8月31日股东人数35458户
股市必读：派林生物新发布《关于回购公司股份的进展公告》
证券之星 · 09-03
股市必读：派林生物新发布《关于回购公司股份的进展公告》
派林生物（000403）披露回购公司股份进展公告，9月1日股价下跌0.1%
证券之星 · 09-01
派林生物（000403）披露回购公司股份进展公告，9月1日股价下跌0.1%
每周股票复盘：派林生物（000403）上半年净利降64.25%
证券之星 · 08-30
每周股票复盘：派林生物（000403）上半年净利降64.25%
派林生物(000403)8月20日股东户数3.69万户，较上期减少0.22%
证券之星 · 08-25
派林生物(000403)8月20日股东户数3.69万户，较上期减少0.22%
派林生物（000403）披露2026年半年度报告，8月24日股价下跌3.48%
证券之星 · 08-24
派林生物（000403）披露2026年半年度报告，8月24日股价下跌3.48%
派林生物：公司将于2026年9月9日召开2026年第三次临时股东会
证券日报网 · 08-23
派林生物：公司将于2026年9月9日召开2026年第三次临时股东会
图解派林生物中报：第二季度单季净利润同比下降58.19%
证券之星 · 08-23
图解派林生物中报：第二季度单季净利润同比下降58.19%
每周股票复盘：派林生物（000403）股东户数增至3.69万
证券之星 · 08-23
每周股票复盘：派林生物（000403）股东户数增至3.69万
派林生物(000403)8月10日股东户数3.69万户，较上期增加0.53%
证券之星 · 08-18
派林生物(000403)8月10日股东户数3.69万户，较上期增加0.53%
派林生物：公司截止2026年8月10日股东人数36934户
证券之星 · 08-18
派林生物：公司截止2026年8月10日股东人数36934户
每周股票复盘：派林生物（000403）回购进展公布，已回购1.31%股份
证券之星 · 08-09
每周股票复盘：派林生物（000403）回购进展公布，已回购1.31%股份
股市必读：派林生物新发布《关于回购公司股份的进展公告》
证券之星 · 08-05
股市必读：派林生物新发布《关于回购公司股份的进展公告》
加载更多
公司概况
公司名称：
派斯双林生物制药股份有限公司
所属行业：
医药制造业
上市日期：
1996-06-28
主营业务：
派斯双林生物制药股份有限公司的主营业务是血液制品的研发、生产和销售。公司的主要产品是人血白蛋白、静注人免疫球蛋白(pH4)、人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白、狂犬病人免疫球蛋白、人凝血因子Ⅷ、人凝血酶原复合物。
发行价格：
3.78
{"stockData":{"symbol":"000403","market":"SZ","secType":"STK","nameCN":"派林生物","latestPrice":9.96,"timestamp":1791529437000,"preClose":9.84,"halted":0,"volume":9259280,"delay":0,"changeRate":0.0122,"floatShares":941000000,"shares":950000000,"eps":0.2818,"marketStatus":"已收盘","change":0.12,"latestTime":"10-09 15:00:00","open":9.86,"high":10.07,"low":9.83,"amount":91934300,"amplitude":0.0244,"askPrice":9.97,"askSize":9,"bidPrice":9.96,"bidSize":41,"shortable":0,"etf":0,"ttmEps":0.2818,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1791768600000},"marketStatusCode":5,"adr":0,"adjPreClose":9.84,"symbolType":"stock","openAndCloseTimeList":[[1791509400000,1791516600000],[1791522000000,1791529200000]],"highLimit":10.82,"lowLimit":8.86,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":950397386,"isCdr":false,"pbRate":1.16,"roa":"--","peRate":35.344216,"roe":"1.04%","epsLYR":0.44,"committee":0.0823,"marketValue":9466000000,"turnoverRate":0.0098,"status":0,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-10-12。","floatMarketCap":9369000000},"requestUrl":"/m/hq/s/000403","defaultTab":"news","newsList":[{"id":"2673600504","title":"派林生物（000403）披露回购公司股份进展公告，10月8日股价下跌2.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2673600504","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673600504?lang=zh_cn&edition=full","pubTime":"2026-10-08 22:59","pubTimestamp":1791471549,"startTime":"0","endTime":"0","summary":"截至2026年10月8日收盘，派林生物报收于9.84元，较前一交易日下跌2.19%，最新总市值为93.52亿元。该股当日开盘10.05元，最高10.14元，最低9.78元，成交额达5991.21万元，换手率为0.64%。近日，派林生物披露《关于回购公司股份的进展公告》。本次回购符合既定方案及相关法规要求。公司后续将根据市场情况继续实施回购，并按规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800035024.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2673049724","title":"派林生物（000403）9月30日主力资金净买入166.41万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2673049724","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2673049724?lang=zh_cn&edition=full","pubTime":"2026-10-08 09:06","pubTimestamp":1791421582,"startTime":"0","endTime":"0","summary":"证券之星消息，截至2026年9月30日收盘，派林生物报收于10.06元，上涨3.29%，换手率0.77%，成交量7.21万手，成交额7224.44万元。9月30日的资金流向数据方面，主力资金净流入166.41万元，占总成交额2.3%，游资资金净流出528.31万元，占总成交额7.31%，散户资金净流入361.91万元，占总成交额5.01%。融券方面，融券卖出5500.0股，融券偿还300.0股，融券余量22.9万股，融券余额230.4万元。派林生物主营业务：血液制品的研究、开发、生产和销售。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026100800002972.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666997515","title":"股市必读：派林生物新发布《北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2026年第三次临时股东会的法律意见书》","url":"https://stock-news.laohu8.com/highlight/detail?id=2666997515","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666997515?lang=zh_cn&edition=full","pubTime":"2026-09-11 03:54","pubTimestamp":1789070077,"startTime":"0","endTime":"0","summary":"公司公告汇总北京市嘉源律师事务所关于派斯双林生物制药股份有限公司2026年第三次临时股东会的法律意见书北京市嘉源律师事务所对派斯双林生物制药股份有限公司2026年第三次临时股东会的召集、召开程序、出席会议人员资格、召集人资格、表决程序及表决结果进行了见证。会议召集、召开程序及表决结果合法有效，北京市嘉源律师事务所出具了法律意见书。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091100011605.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","03069","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2666956275","title":"派林生物（000403）披露2026年度中期利润分配方案，9月10日股价下跌1.71%","url":"https://stock-news.laohu8.com/highlight/detail?id=2666956275","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2666956275?lang=zh_cn&edition=full","pubTime":"2026-09-10 18:24","pubTimestamp":1789035862,"startTime":"0","endTime":"0","summary":"截至2026年9月10日收盘，派林生物报收于10.33元，较前一交易日下跌1.71%，最新总市值为98.18亿元。该股当日开盘10.47元，最高10.47元，最低10.28元，成交额达3407.79万元，换手率为0.35%。公司于近日披露《2026年第三次临时股东会决议公告》，显示派斯双林生物制药股份有限公司于2026年9月9日召开2026年第三次临时股东会，会议采用现场投票与网络投票相结合方式，审议通过了《2026年度中期利润分配方案》。出席会议的股东共263人，代表有表决权股份总数的22.6860%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026091000035359.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2665366332","title":"每周股票复盘：派林生物（000403）股东户数下降3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2665366332","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2665366332?lang=zh_cn&edition=full","pubTime":"2026-09-06 03:09","pubTimestamp":1788635350,"startTime":"0","endTime":"0","summary":"截至2026年9月4日收盘，派林生物报收于10.35元，较上周的10.59元下跌2.27%。9月2日盘中最低价报10.17元。本周关注点股本股东变化：股东户数较8月20日减少3.78%，户均持股上升至2.68万股。公司公告汇总：截至8月31日已回购股份12,423,491股，成交总金额1.34亿元。股本股东变化股东户数变动截至2026年8月31日，派林生物股东户数为3.55万户，较8月20日减少1393.0户，减幅为3.78%。回购进展符合既定方案及法规要求，后续将视市场情况持续推进并履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090600001017.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0239","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664382626","title":"派林生物半年报遇冷：业绩加速下滑，多重风险交织","url":"https://stock-news.laohu8.com/highlight/detail?id=2664382626","media":"新浪证券","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664382626?lang=zh_cn&edition=full","pubTime":"2026-09-04 15:25","pubTimestamp":1788506700,"startTime":"0","endTime":"0","summary":"01政策冲击下盈利大幅受挫，业绩反转尚存不确定性派林生物将 2026 年上半年业绩急转直下主要归因于行业政策调整。双重因素叠加，公司血液制品毛利率从去年同期 47.70% 跌落至 32.75%，同比下滑 14.95 个百分点。但该判断仍存在变数，医保控费、集采扩围属于行业长期趋势，处方量的恢复节奏难以预判，政策带来的毛利率下行压力或将长期存在，业绩能否顺利修复仍有待验证。2026 年上半年研发投入 4292.18 万元，同比下降 26.27%，下滑幅度超过营收降幅。","market":"other","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/aigcy/2026-09-04/doc-iniqryeu0875819.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664099878","title":"派林生物(000403)8月31日股东户数3.55万户，较上期减少3.78%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664099878","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664099878?lang=zh_cn&edition=full","pubTime":"2026-09-03 17:29","pubTimestamp":1788427793,"startTime":"0","endTime":"0","summary":"证券之星消息，近日派林生物披露，截至2026年8月31日公司股东户数为3.55万户，较8月20日减少1393.0户，减幅为3.78%。在生物制品行业个股中，派林生物股东户数低于行业平均水平，截至8月31日，生物制品行业平均股东户数为3.56万户。根据统计，派林生物2026年8月20日至2026年8月31日，主力资金净流出265.28万元，游资资金净流入502.2万元，散户资金净流出236.92万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300031471.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000403","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664825649","title":"派林生物：公司截止2026年8月31日股东人数35458户","url":"https://stock-news.laohu8.com/highlight/detail?id=2664825649","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664825649?lang=zh_cn&edition=full","pubTime":"2026-09-03 11:37","pubTimestamp":1788406665,"startTime":"0","endTime":"0","summary":"证券之星消息，派林生物(000403)09月02日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司截止2026.08.31日的最新股东人数是多少人？谢谢派林生物回复：尊敬的投资者，您好！公司截止2026年8月31日股东人数35458户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300017416.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664846542","title":"股市必读：派林生物新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2664846542","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664846542?lang=zh_cn&edition=full","pubTime":"2026-09-03 02:55","pubTimestamp":1788375312,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年8月31日，派林生物已回购股份12,423,491股，占总股本1.31%，成交总金额1.3387亿元，回购进展符合方案要求。公司公告汇总关于回购公司股份的进展公告派斯双林生物制药股份有限公司于2026年4月27日召开董事会，审议通过以集中竞价方式回购股份的议案，拟使用自有资金或自筹资金不低于20,000万元且不超过30,000万元，回购价格不超过19.50元/股，回购期限为董事会审议通过之日起12个月内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090300002374.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2664857450","title":"派林生物（000403）披露回购公司股份进展公告，9月1日股价下跌0.1%","url":"https://stock-news.laohu8.com/highlight/detail?id=2664857450","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2664857450?lang=zh_cn&edition=full","pubTime":"2026-09-01 22:44","pubTimestamp":1788273857,"startTime":"0","endTime":"0","summary":"截至2026年9月1日收盘，派林生物报收于10.41元，较前一交易日下跌0.1%，最新总市值为98.94亿元。该股当日开盘10.43元，最高10.52元，最低10.35元，成交额达5819.08万元，换手率为0.59%。近日，派林生物披露《关于回购公司股份的进展公告》。本次回购符合既定方案及相关法规要求。公司后续将根据市场情况继续实施回购，并按规定履行信息披露义务。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026090100043273.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2663048570","title":"每周股票复盘：派林生物（000403）上半年净利降64.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2663048570","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2663048570?lang=zh_cn&edition=full","pubTime":"2026-08-30 05:47","pubTimestamp":1788040029,"startTime":"0","endTime":"0","summary":"截至2026年8月28日收盘，派林生物报收于10.59元，较上周的10.63元下跌0.38%。本周，派林生物8月26日盘中最高价报11.21元。本周关注点来自业绩披露要点：2026年上半年归属于上市公司股东的净利润同比下降64.25%。股本股东变化截至2026年8月20日，公司股东户数为3.69万户，较8月10日减少83.0户，减幅0.22%。截至2026年6月30日，公司回购股份金额为115,975,113.73元，分红与回购合计金额占2025年度归母净利润的61.22%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026083000001758.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2662738621","title":"派林生物(000403)8月20日股东户数3.69万户，较上期减少0.22%","url":"https://stock-news.laohu8.com/highlight/detail?id=2662738621","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2662738621?lang=zh_cn&edition=full","pubTime":"2026-08-25 17:42","pubTimestamp":1787650978,"startTime":"0","endTime":"0","summary":"证券之星消息，近日派林生物披露，截至2026年8月20日公司股东户数为3.69万户，较8月10日减少83.0户，减幅为0.22%。在生物制品行业个股中，派林生物股东户数高于行业平均水平，截至8月20日，生物制品行业平均股东户数为3.55万户。根据统计，派林生物2026年8月10日至2026年8月20日，主力资金净流入2001.17万元，游资资金净流入5860.51万元，散户资金净流出7861.68万元。以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082500036936.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","000403","BK0071"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661474220","title":"派林生物（000403）披露2026年半年度报告，8月24日股价下跌3.48%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661474220","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661474220?lang=zh_cn&edition=full","pubTime":"2026-08-24 18:18","pubTimestamp":1787566729,"startTime":"0","endTime":"0","summary":"截至2026年8月24日收盘，派林生物报收于10.26元，较前一交易日下跌3.48%，最新总市值为97.51亿元。该股当日开盘10.6元，最高10.61元，最低10.26元，成交额达1.03亿元，换手率为1.05%。公司于2026年8月24日披露《2026年半年度报告》。本报告期末总资产9,784,679,213.08元，较上年度末增长3.36%；归属于上市公司股东的净资产8,056,252,246.81元，较上年度末下降0.39%。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082400026190.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0071","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661436312","title":"派林生物：公司将于2026年9月9日召开2026年第三次临时股东会","url":"https://stock-news.laohu8.com/highlight/detail?id=2661436312","media":"证券日报网","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661436312?lang=zh_cn&edition=full","pubTime":"2026-08-23 21:31","pubTimestamp":1787491860,"startTime":"0","endTime":"0","summary":"证券日报网讯8月23日，派林生物发布公告称，公司将于2026年9月9日召开2026年第三次临时股东会。","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"sina","url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-23/doc-inipiiqm0443602.shtml","rn_cache_url":null,"customStyle":"body{padding-top:10px;}.art_tit_h1{#titleStyle#}a{#lv2TextColor#}.art_time, .art_cite{#sourceStyle#;} .art_cite{margin-left: 3px;}","selectors":".module-article, article","filters":"header, .voice2, .tags, #norm_qrcode_link_auto, .unfold-box, .action","directOrigin":true},"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.sina.com.cn/stock/relnews/cn/2026-08-23/doc-inipiiqm0443602.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"sina","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661224888","title":"图解派林生物中报：第二季度单季净利润同比下降58.19%","url":"https://stock-news.laohu8.com/highlight/detail?id=2661224888","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661224888?lang=zh_cn&edition=full","pubTime":"2026-08-23 17:38","pubTimestamp":1787477898,"startTime":"0","endTime":"0","summary":"证券之星消息，派林生物2026年中报显示，上半年度公司主营收入8.3亿元，同比下降15.88%；归母净利润8430.1万元，同比下降64.25%；扣非净利润6480.97万元，同比下降69.81%；其中2026年第二季度，公司单季度主营收入4.87亿元，同比下降20.42%；单季度归母净利润6133.21万元，同比下降58.19%；单季度扣非净利润5183.13万元，同比下降62.5%；负债率17.73%，投资收益353.86万元，财务费用-1193.14万元，毛利率32.92%。财报数据概要请见下图:本文数据来源于派林生物2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300008645.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661421108","title":"每周股票复盘：派林生物（000403）股东户数增至3.69万","url":"https://stock-news.laohu8.com/highlight/detail?id=2661421108","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661421108?lang=zh_cn&edition=full","pubTime":"2026-08-23 02:51","pubTimestamp":1787424668,"startTime":"0","endTime":"0","summary":"截至2026年8月21日收盘，派林生物报收于10.63元，较上周的10.9元下跌2.48%。本周，派林生物8月20日盘中最高价报11.28元。8月19日盘中最低价报10.6元。派林生物当前最新总市值101.03亿元，在生物制品板块市值排名29/51，在两市A股市值排名1787/5210。股本股东变化：户均持股数量由2.59万股降至2.57万股，户均持股市值为27.46万元。股本股东变化股东户数变动近日派林生物披露，截至2026年8月10日公司股东户数为3.69万户，较7月10日增加193.0户，增幅为0.53%。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082300000554.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","000403","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660646597","title":"派林生物(000403)8月10日股东户数3.69万户，较上期增加0.53%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660646597","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660646597?lang=zh_cn&edition=full","pubTime":"2026-08-18 17:27","pubTimestamp":1787045277,"startTime":"0","endTime":"0","summary":"证券之星消息，近日派林生物披露，截至2026年8月10日公司股东户数为3.69万户，较7月10日增加193.0户，增幅为0.53%。户均持股数量由上期的2.59万股减少至2.57万股，户均持股市值为27.46万元。在生物制品行业个股中，派林生物股东户数高于行业平均水平，截至8月10日，生物制品行业平均股东户数为3.53万户。根据统计，派林生物2026年7月10日至2026年8月10日，主力资金净流出6498.88万元，游资资金净流出1554.38万元，散户资金净流入8053.26万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800030515.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660045060","title":"派林生物：公司截止2026年8月10日股东人数36934户","url":"https://stock-news.laohu8.com/highlight/detail?id=2660045060","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660045060?lang=zh_cn&edition=full","pubTime":"2026-08-18 15:39","pubTimestamp":1787038755,"startTime":"0","endTime":"0","summary":"证券之星消息，派林生物(000403)08月18日在投资者关系平台上答复投资者关心的问题。投资者提问：董秘您好，请问公司截止2026.08.10日的最新股东人数是多少人？谢谢派林生物回复：尊敬的投资者，您好！公司截止2026年8月10日股东人数36934户。谢谢！本文数据来源于深圳证券交易所互动易，仅供参考不构成投资建议。责任编辑：陈思雨","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800022371.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658758026","title":"每周股票复盘：派林生物（000403）回购进展公布，已回购1.31%股份","url":"https://stock-news.laohu8.com/highlight/detail?id=2658758026","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658758026?lang=zh_cn&edition=full","pubTime":"2026-08-09 02:28","pubTimestamp":1786213693,"startTime":"0","endTime":"0","summary":"截至2026年8月7日收盘，派林生物报收于10.6元，较上周的10.43元上涨1.63%。本周关注点公司公告汇总：截至2026年7月31日，公司已回购股份12,423,491股，占总股本的1.31%公司公告汇总派斯双林生物制药股份有限公司于2026年4月27日召开董事会，审议通过以集中竞价方式回购股份的议案。公司拟使用自有或自筹资金不低于20,000万元且不超过30,000万元，以不超过19.50元/股的价格回购A股股份，回购期限为董事会审议通过之日起12个月内。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080900000695.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0071","BK0239","000403"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2657565738","title":"股市必读：派林生物新发布《关于回购公司股份的进展公告》","url":"https://stock-news.laohu8.com/highlight/detail?id=2657565738","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2657565738?lang=zh_cn&edition=full","pubTime":"2026-08-05 03:13","pubTimestamp":1785870790,"startTime":"0","endTime":"0","summary":"公司公告汇总：截至2026年7月31日，派林生物已回购股份12,423,491股，占总股本1.31%，成交总金额1.3387亿元，回购进展符合方案及法规要求。公司公告汇总关于回购公司股份的进展公告派斯双林生物制药股份有限公司于2026年4月27日召开董事会，审议通过以集中竞价方式回购股份的议案。公司拟使用自有或自筹资金不低于20,000万元且不超过30,000万元，以不超过19.50元/股的价格回购A股股份，回购期限为董事会审议通过之日起12个月内。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026080500002526.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["000403","BK0239","BK0071"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1791668139398,"stockEarnings":[{"period":"1week","weight":-0.0099},{"period":"1month","weight":-0.0523},{"period":"3month","weight":0.0803},{"period":"6month","weight":-0.2231},{"period":"1year","weight":-0.3908},{"period":"ytd","weight":-0.2725}],"compareEarnings":[{"period":"1week","weight":-0.0074},{"period":"1month","weight":-0.0349},{"period":"3month","weight":-0.0456},{"period":"6month","weight":-0.0433},{"period":"1year","weight":-0.0305},{"period":"ytd","weight":-0.0391}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"派斯双林生物制药股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"35458人(较上一季度减少3.78%)","perCapita":"26529股","listingDate":"1996-06-28","address":"山西省太原市晋源区长兴南街8号阳光城环球金融中心3004室","registeredCapital":"95039万元","survey":" 派斯双林生物制药股份有限公司的主营业务是血液制品的研发、生产和销售。公司的主要产品是人血白蛋白、静注人免疫球蛋白(pH4)、人免疫球蛋白、乙型肝炎人免疫球蛋白、破伤风人免疫球蛋白、狂犬病人免疫球蛋白、人凝血因子Ⅷ、人凝血酶原复合物。","listedPrice":3.78},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.50.1","shortVersion":"4.50.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"派林生物(000403)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供派林生物(000403)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"派林生物,000403,派林生物股票,派林生物股票老虎,派林生物股票老虎国际,派林生物行情,派林生物股票行情,派林生物股价,派林生物股市,派林生物股票价格,派林生物股票交易,派林生物股票购买,派林生物股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"派林生物(000403)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供派林生物(000403)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}